The 4.65% investment-grade notes are due 2026

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering by Illumina, Inc. of $500 million aggregate principal amount of 4.650% notes due 2026.

Founded in 1998, Illumina is a global leader in sequencing- and array-based solutions for genetic and genomic analysis. The company’s products and services serve customers in a wide range of markets, enabling the adoption of genomic solutions in research and clinical settings.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Bex Childress and Jared Madnick. The tax team included partner Mario J. Verdolini and associate Ted Lee. The intellectual property team included partner David R. Bauer and associate Gabrielle Mazero. Associates Caleb Beavers and Jonathan P. Jackson provided 1940 Act advice. Members of the Davis Polk team are based in the Northern California and the New York offices.

Copy link to share post